α-Lipoic acid prolongs survival and attenuates acute kidney injury in a rat model of sepsis

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 7, 2014, Pages 459-468

  Li, Guofu ^a   Gao, Linlin ^a   Jia, Jia ^a   Gong, Xiaoying ^a   Zang, Bin ^a   Chen, Weimin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Nuclear factor B; Proinflammatory cytokines; Sepsis; lipoic acid

Indexed keywords

BETA ACTIN; CREATININE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; THIOCTIC ACID; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; KIDNEY INJURY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; MORTALITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; SEPTIC SHOCK; SURVIVAL; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANIMAL; CECUM; COMPLICATION; INJURIES; LIGATION; PATHOLOGY; PUNCTURE; SEPSIS; SPRAGUE DAWLEY RAT;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; CECUM; LIGATION; MALE; NF-KAPPA B; PUNCTURES; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; THIOCTIC ACID;

EID: 84903908242     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12244     Document Type: Article

References (57)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N. Engl. J. Med. 2013; 369: 840-51.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003; 348: 1546-54.
3. Levy MM, Dellinger RP, Townsend SR et al. The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Crit. Care Med. 2010; 38: 367-74.
4. de Montmollin E, Annane D. Year in review 2010: Critical care: Multiple organ dysfunction and sepsis. Crit. Care 2011; 15: 236-41.
5. Bagshaw SM, Uchino S, Bellomo R et al. Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin. J. Am. Soc. Nephrol. 2007; 2: 431-9.
6. Leelahavanichkul A, Yasuda H, Doi K et al. Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. Am. J. Physiol. Renal Physiol. 2008; 295: F1825-35.
7. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B. Lipoic acid: Biological activity and therapeutic potential. Pharmacol. Rep. 2011; 63: 849-58.
8. Bilska A, Wlodek L. Lipoic acid: The drug of the future? Pharmacol. Rep. 2005; 57: 570-7.
9. Arambasic J, Mihailovic M, Uskokovic A et al. Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. Eur. J. Nutr. 2013; 52: 1461-73.
10. Wang L, Wu CG, Fang CQ et al. The protective effect of alpha-lipoic acid on mitochondria in the kidney of diabetic rats. Int. J. Clin. Exp. Med. 2013; 6: 90-7.
11. He L, Liu B, Dai Z et al. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur. J. Pharmacol. 2012; 678: 32-8.
12. Xie R, Li X, Ling Y et al. Alpha-lipoic acid pre- and post-treatments provide protection against in vitro ischemia-reperfusion injury in cerebral endothelial cells via Akt/mTOR signaling. Brain Res. 2012; 1482: 81-90.
13. Deng C, Sun Z, Tong G et al. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway. PLoS ONE 2013; 8: e58371.
14. Morsy MA, Abdalla AM, Mahmoud AM, Abdelwahab SA, Mahmoud ME. Protective effects of curcumin, alpha-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats. J. Physiol. Biochem. 2012; 68: 29-35.
15. Kaya M, Yildirim CH, Kosemehmetoglu K et al. Alpha-lipoic acid reduces peridural fibrosis after laminectomy of lumbar vertebrae in rabbits. Acta Neurochir. 2012; 154: 1241-5.
16. Lee JE, Yi CO, Jeon BT et al. α-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Cardiovasc. Diabetol. 2012; 11: 111-20.
17. Farr SA, Price TO, Banks WA, Ercal N, Morley JE. Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice. J. Alzheimers Dis. 2012; 32: 447-55.
18. Liu B, Ma X, Guo D, Guo Y, Chen N, Bi H. Neuroprotective effect of alpha-lipoic acid on hydrostatic pressure-induced damage of retinal ganglion cells in vitro. Neurosci. Lett. 2012; 526: 24-8.
19. Cadirci E, Altunkaynak BZ, Halici Z et al. Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 2010; 33: 479-84.
20. Bagshaw SM, Bennett M, Haase M et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010; 36: 452-61.
21. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 2003; 35: 535-44.
22. Tak PP, Firestein GS. NF-kappaB: A key role in inflammatory diseases. J. Clin. Invest. 2001; 107: 7-11.
23. Hubbard WJ, Choudhry M, Schwacha MG et al. Cecal ligation and puncture. Shock 2005; 24(Suppl. 1): 52-7.
24. Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J. Clin. Invest. 2009; 119: 2868-78.
25. Cremer DR, Rabeler R, Roberts A, Lynch B. Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. Regul. Toxicol. Pharmacol. 2006; 46: 193-201.
26. Cremer DR, Rabeler R, Roberts A, Lynch B. Safety evaluation of alpha-lipoic acid (ALA). Regul. Toxicol. Pharmacol. 2006; 46: 29-41.
27. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al. Could neutrophil-gelatinase-associated lipocalin and cystatin c predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press. Res. 2007; 30: 408-15.
28. Bennett M, Dent CL, Ma Q et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin. J. Am. Soc. Nephrol. 2008; 3: 665-73.
29. Schmidt-Ott KM, Mori K, Li JY et al. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2007; 18: 407-13.
30. Demarco VG, Scumpia PO, Bosanquet JP, Skimming JW. Alpha-lipoic acid inhibits endotoxin-stimulated expression of iNOS and nitric oxide independent of the heat shock response in RAW 264.7 cells. Free Radic. Res. 2004; 38: 675-82.
31. Sung MJ, Kim W, Ahn SY et al. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ. Res. 2005; 97: 880-90.
32. Vanasco V, Cimolai MC, Evelson P, Alvarez S. The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by alpha-lipoic acid. Free Radic. Res. 2008; 42: 815-23.
33. Zhang WJ, Wei H, Hagen T, Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl Acad. Sci. USA 2007; 104: 4077-82.
34. Veljkovic AR, Nikolic RS, Kocic GM et al. Protective effects of glutathione and lipoic acid against cadmium-induced oxidative stress in rat's kidney. Renal Fail. 2012; 34: 1281-7.
35. El-Nakib GA, Mostafa TM, Abbas TM, El-Shishtawy MM, Mabrouk MM, Sobh MA. Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis. Int. J. Nephrol. Renovasc. Dis. 2013; 6: 161-8.
36. Cavdar Z, Ozbal S, Celik A et al. The effects of alpha-lipoic acid on MMP-2 and MMP-9 activities in a rat renal ischemia and re-perfusion model. Biotech. Histochem. 2014; 89: 304-14.
37. Wongmekiat O, Leelarungrayub D, Thamprasert K. Alpha-lipoic acid attenuates renal injury in rats with obstructive nephropathy. Biomed. Res. Int. 2013; 2013(138): 719.
38. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 1996; 64: 4733-8.
39. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 1988; 81: 1162-72.
40. Huang W, Tang Y, Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010; 51: 119-26.
41. Angus DC, Yang L, Kong L et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit. Care Med. 2007; 35: 1061-7.
42. Ulloa L, Ochani M, Yang H et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl Acad. Sci. USA 2002; 99(12): 351-6.
43. Wang H, Liao H, Ochani M et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004; 10: 1216-21.
44. Abraham E, Laterre PF, Garbino J et al. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter Phase III trial with 1, 342 patients. Crit. Care Med. 2001; 29: 503-10.
45. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007; 87: 315-424.
46. Heemskerk S, Pickkers P, Bouw MP et al. Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin. J. Am. Soc. Nephrol. 2006; 1: 853-62.
47. Okamoto I, Abe M, Shibata K et al. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 2000; 162: 716-22.
48. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG, Rich GF. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth. Analg. 2001; 92: 681-7.
49. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R. Cigarette smoke triggers macrophage adhesion and activation. Role of lipid peroxidation products and scavenger receptor. Free Radic. Biol. Med. 2003; 35: 697-710.
50. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules. NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995; 9: 899-909.
51. Liu SF, Malik AB. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 290: L622-45.
52. Bohrer H, Qiu F, Zimmermann T et al. Role of NFkappaB in the mortality of sepsis. J. Clin. Invest. 1997; 100: 972-85.
53. Arnalich F, Garcia-Palomero E, Lopez J et al. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect. Immun. 2000; 68: 1942-5.
54. Kim HS, Kim HJ, Park KG et al. Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Exp. Mol. Med. 2007; 39: 106-13.
55. Ying Z, Kampfrath T, Sun Q, Parthasarathy S, Rajagopalan S. Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function. Inflamm. Res. 2011; 60: 219-25.
56. Yoo TH, Lee JH, Chun HS, Chi SG. α-Lipoic acid prevents p53 degradation in colon cancer cells by blocking NF-kappaB induction of RPS6KA4. Anticancer Drugs 2013; 24: 555-65.
57. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009; 4: 31-6.